New Biotech Billionaire Minted In Caris Life Sciences IPO

forbes.com/sites/amyfeldman/2025/06/18/new-biotech-billionaire-minted-in-caris-life-sciences-ipo

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.
David Dean Halbert acquired an early-stage life sciences company called Molecular Profiling Institute in 2008 to develop a blood-based platform for early disease detection.…

This story appeared on forbes.com, 2025-06-18 19:53:27.
The Entire Business World on a Single Page. Free to Use →